Cardiotoxicity of Cancer Therapy: Disease Burden and Mechanisms

Overview

This tutorial will provide an overview of the emerging field of Cardio-Oncology and associated cardiotoxicity. The AHA/ACC Heart Failure Guidelines define individuals with exposure to cardiotoxic medications, as ‘at risk’ for heart failure, or Stage A. An understanding of the types of oncologic treatments and the pathophysiological mechanisms that are associated with cardiotoxicity provides the foundation for optimal cardiovascular care and surveillance of patients receiving cardiotoxic agents.   

NO CREDIT OFFERED. Available on DVD/Streaming Video or Streaming Video only.

Price: $40-$50

Live Courses

Back to Top